KMT2B and cancer: Although HBV DNA insertional sites appear to be randomly distributed throughout the host genome, the recent use of next-generation sequencing (NGS) approaches has led to the identification of HBV integration enrichment into specific cancer-driver genes, including TERT, MLL4, CCNE1 and CCNA2, in tumour tissues7,10–16.